Efficacy of Inhaling Bronchodilator Medications in Patients With Chronic Obstructive Pulmonary Disease Who Have a Low Peak Inspiratory Flow Rate.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2013
At a glance
- Drugs Arformoterol (Primary) ; Salmeterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 28 Sep 2012 Planned End Date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 14 Jul 2011 New trial record